These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Using RNA interference to identify the different roles of SMAD2 and SMAD3 in NIH/3T3 fibroblast cells. Zheng R; Xiong Q; Zuo B; Jiang S; Li F; Lei M; Deng C; Xiong Y Cell Biochem Funct; 2008; 26(5):548-56. PubMed ID: 18506886 [TBL] [Abstract][Full Text] [Related]
5. Smad3 mediates TGF-beta1-induced collagen gel contraction by human lung fibroblasts. Kobayashi T; Liu X; Wen FQ; Kohyama T; Shen L; Wang XQ; Hashimoto M; Mao L; Togo S; Kawasaki S; Sugiura H; Kamio K; Rennard SI Biochem Biophys Res Commun; 2006 Jan; 339(1):290-5. PubMed ID: 16298342 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of mitochondrial Nox4 mediates TGF-β-induced apoptosis in cultured mouse podocytes. Das R; Xu S; Quan X; Nguyen TT; Kong ID; Chung CH; Lee EY; Cha SK; Park KS Am J Physiol Renal Physiol; 2014 Jan; 306(2):F155-67. PubMed ID: 24259511 [TBL] [Abstract][Full Text] [Related]
7. Apocynin inhibits the upregulation of TGF-β1 expression and ROS production induced by TGF-β in skeletal muscle cells. Abrigo J; Morales MG; Simon F; Cabrera D; Di Capua G; Cabello-Verrugio C Phytomedicine; 2015 Sep; 22(10):885-93. PubMed ID: 26321737 [TBL] [Abstract][Full Text] [Related]
8. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899 [TBL] [Abstract][Full Text] [Related]
9. Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats. Zhao M; Zheng S; Yang J; Wu Y; Ren Y; Kong X; Li W; Xuan J PLoS One; 2015; 10(3):e0121312. PubMed ID: 25793583 [TBL] [Abstract][Full Text] [Related]
10. [Adrenomedullin inhibits TGF-β1-induced procollagen expression in cultured human fetal lung fibroblasts via Smad2/3 pathway]. Hao S; Wang W; Yu Z; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1125-8. PubMed ID: 25374072 [TBL] [Abstract][Full Text] [Related]
11. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway. Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969 [TBL] [Abstract][Full Text] [Related]
12. Curcumin ameliorates renal fibrosis by inhibiting local fibroblast proliferation and extracellular matrix deposition. Zhou X; Zhang J; Xu C; Wang W J Pharmacol Sci; 2014; 126(4):344-50. PubMed ID: 25452269 [TBL] [Abstract][Full Text] [Related]
13. Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model, OLETF rats. Furuse Y; Hashimoto N; Maekawa M; Toyama Y; Nakao A; Iwamoto I; Sakurai K; Suzuki Y; Yagui K; Yuasa S; Toshimori K; Saito Y Nephron Exp Nephrol; 2004; 98(3):e100-8. PubMed ID: 15528945 [TBL] [Abstract][Full Text] [Related]
14. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway. Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β/Smad signalling in diabetic nephropathy. Lan HY Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842 [TBL] [Abstract][Full Text] [Related]
16. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions. Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010 [TBL] [Abstract][Full Text] [Related]
17. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro. Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074 [TBL] [Abstract][Full Text] [Related]
18. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Jinnin M; Ihn H; Tamaki K Mol Pharmacol; 2006 Feb; 69(2):597-607. PubMed ID: 16288083 [TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end-products accelerate the cardiac aging process through the receptor for advanced glycation end-products/transforming growth factor-β-Smad signaling pathway in cardiac fibroblasts. Fang M; Wang J; Li S; Guo Y Geriatr Gerontol Int; 2016 Apr; 16(4):522-7. PubMed ID: 26016731 [TBL] [Abstract][Full Text] [Related]
20. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC; de Caestecker MP; Schnaper HW Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]